Home dialysis therapies
Clinical Medicine · 2023-05 · 23 (3) · 259-261
DOI: 10.7861/clinmed.2023-rm4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine, 2023-05. Verfasst von Richard W Corbett. Beteiligte Einrichtung: Imperial College Healthcare NHS Trust, London, UK richard.corbett@imperial.ac.uk. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Peritoneal Dialysis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Home dialysis therapies offer a significant benefit to patients in respect of quality of life and autonomy, as compared with in-centre haemodialysis. There is significant unwarranted variation across the world in the availability of both peritoneal dialysis (PD) and home haemodialysis, which has led in the UK to a recommendation of a minimum 20% prevalent rate of dialysis patients at home. Key advances in PD have included changes in the approach to prescribing PD and the use of assisted dialysis. Peritonitis remains a significant complication which may present to general physicians and needs prompt recognition and treatment. The development of novel small dialysis machines has led to a resurgence of interest in home haemodialysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Imperial College Healthcare NHS Trust, London, UK richard.corbett@imperial.ac.uk.
Zitieren
APA
Corbett, R. W. (2023). Home dialysis therapies. Clinical Medicine, 23(3), 259-261. https://doi.org/10.7861/clinmed.2023-rm4
Vancouver
Corbett RW. Home dialysis therapies. Clinical Medicine. 2023;23(3):259-261. doi:10.7861/clinmed.2023-rm4
BibTeX
@article{Corbett2023,
author = {Corbett, Richard W},
title = {Home dialysis therapies},
journal = {Clinical Medicine},
year = {2023},
volume = {23},
number = {3},
pages = {259--261},
doi = {10.7861/clinmed.2023-rm4}
}
EUVIMED